CNO Financial Group (CNO) Q3 2026 earnings review
CNO Financial lifts its profit outlook, but Medicare margins shrink
CNO Financial Group, which sells insurance and annuities to middle-income Americans, beat its second-half pace through investment spreads while its Medicare health margin shrank. Operating profit per share excluding the annual assumption review jumped 48% from a year ago to $1.42, driven by a 72% climb in unallocated investment income and higher annuity margins. Chief executive Gary C. Bhojwani raised the full-year profit outlook midpoint by 9%, though by our math the new target still points to a 5% profit drop in the fourth quarter.
| Profit per share, excluding one-offs | $1.42 +48% from a year ago (excludes $0.48 actuarial gain) |
|---|---|
| Unallocated investment income | $68.1M +72% from a year ago |
| Medicare supplement margin | 2% 22% last quarter and 14% a year ago |
| Full-year profit per share outlook | Raised 9% middle of the range ~$5.12 by our math (+27% YoY) |
⚖️ Verdict: 🟢 Bullish
The story got better because the insurer extended its sales streak to 17 quarters against its hardest comparison of the year and pushed operating return on equity to 14.1%, beating its 2027 target a year early. One caution: Medicare supplement margin fell to 2% of policy income from 14% a year ago on higher policy benefits, and standard book value dropped 7% as bond losses widened.
The question now is whether the third-quarter surge in unallocated investment income and the drop in Medicare supplement margin were both one-quarter swings from the annual review or lasting shifts. If rate increases restore Medicare margins in the fourth quarter while investment spreads hold, CNO will beat its raised plan; if medical claims stay elevated and alternative investment returns cool, fourth-quarter earnings will shrink as the outlook implies. The full quarterly filing and fourth-quarter health margins will settle it.
🐂 Bull Case
Investment Spreads And Annuities Drove The Raise
CNO Financial Group sells life insurance, health policies, and retirement annuities to middle-income Americans. Even after stripping out a $44.9 million gain from its yearly review of policy assumptions, operating profit per share jumped 48% from a year ago to $1.42. That beat prompted chief executive Gary C. Bhojwani to lift the full-year profit outlook by 9% at the middle of the range.
- Unallocated investment income: $68.1 million, up 72% from $39.5 million a year ago
- Annuity product margin, excluding one-offs: $67.4 million, up 20% from a year ago by our math
- Operating return on equity, excluding one-offs: 14.1%, up from 11.2% a year ago and already above the 12% goal originally set for 2027
The insurer is earning more by borrowing from the Federal Home Loan Bank and issuing funding agreements, then investing the cash at higher yields. Investment borrowings rose 31% from a year ago to $3.19 billion, which lifted unallocated investment income and pushed returns past management's multi-year target.
What to watch: fourth-quarter unallocated investment income when CNO reports full-year results in February. A drop back toward $45 million would show that third-quarter alternative investment returns were a spike rather than a new baseline.
Sales And Agent Streaks Reached 17 Quarters
A main worry coming into the quarter was whether CNO could keep growing new annualized premiums (NAP), the first-year value of new life and health policies, against last year's 26% jump. Bhojwani said the company delivered its "17 th consecutive quarter of sales growth" while agent counts in the Consumer and Worksite divisions grew for the 15th and 17th straight quarters.
While the financial supplement in the filing cuts off before the exact new sales table, total collected premiums across all products rose 7.5% from a year ago to $1.22 billion. Annuity cash collections climbed 8.8% to $514.0 million, and health cash collections increased 9.7% to $452.8 million, showing steady customer demand across both retirement and health lines.
What to watch: the exact percentage growth for Consumer and Worksite new annualized premiums in the quarterly filing. A negative reading in Consumer life sales would confirm that worksite and health products are carrying the sales streak.
🐻 Bear Case
Medicare Supplement Margin Dropped To 2%
Bhojwani pointed to "continued improvement in profitability" across the business, and overall health product margin excluding one-offs rose 4.0% from a year ago to $141.3 million. However, the product table shows that Medicare supplement policies, which cover gaps in government health insurance for seniors, saw their margin fall to $3.2 million, or 2% of policy income, down from 22% last quarter and 14% a year ago.
That drop happened because Medicare supplement policy benefits—the medical claims and reserves CNO records for policyholders—jumped 28% from a year ago to $162.4 million, taking 93% of policy income vs 81% last year. A jump in long-term care margin to $56.9 million (73% of policy income) and a $7.8 million gain from the yearly actuarial review masked the Medicare supplement squeeze inside the total health line.
What to watch: the breakdown of the annual actuarial review by product line in the quarterly filing. If Medicare supplement needed a reserve addition during the review, the approved 2026 rate increases are not keeping up with medical claims.
Book Value Fell And Subsidiary Dividends Stopped
Rising interest rates during the quarter reduced the market value of CNO's bond portfolio, widening its accumulated other comprehensive loss by $363.0 million from last quarter to $1.55 billion. That pushed standard book value per share down 7.0% from a year ago to $25.34, even as management highlighted an 8.4% rise in diluted book value excluding bond marks to $41.29.
At the same time, the insurance subsidiaries generated a statutory operating gain of $21.9 million and paid zero dividends to the parent company, while the parent spent $60.0 million buying back shares at $54.52 each (32% above diluted book value excluding bond marks by our math). Parent cash slipped to $230.7 million from $233.2 million in June, leaving fourth-quarter cash targets dependent on regulatory approvals.
What to watch: fourth-quarter dividends paid from the insurance subsidiaries to the parent company. Without a large fourth-quarter transfer, parent liquidity will move closer to its $150 million floor.
Risks This Quarter Didn't Answer
Several standing watch items cannot be read yet because the earnings release omits them and the supplied financial supplement ends at page 10.
- New annualized premiums by division and product: page 11 of the supplement is not in the supplied materials; the quarterly filing will show whether Medicare supplement sales stayed above 20% growth.
- Holding company free cash flow: not in the release; the filing will show how much of the $200 million to $250 million full-year target arrived in the third quarter.
- Expense ratio excluding one-offs: not stated in the release; the filing will test whether second-half overhead costs rose as previously indicated.
- New money yield on investments: lives on page 17 of the supplement; the filing will confirm if yields stayed above 6% for a 15th quarter.
👓 Other Themes
Third Bermuda Deal Triggered A Tax Charge
On October 1, CNO closed a third reinsurance deal with its Bermuda subsidiary, moving about $270 million of Colonial Penn life insurance reserves offshore. Selling bonds before the transfer (
"asset sales in anticipation of executing the internal reinsurance transaction on October 1, 2026") contributed to $48.3 million in realized investment losses and a $22.1 million tax allowance charge because higher interest rates left fewer bond gains to offset those losses.
💲 Other KPIs
Investment income from CNO's main bond and loan portfolio rose 15.3% from a year ago and 7.2% from last quarter. Growth has sped up across the last three quarters (+5.3% in Q1, +8.9% in Q2, +15.3% in Q3) as the insurer puts new cash to work at higher interest rates and expands its institutional borrowing programs.
Total customer funds held in annuities and interest-sensitive life policies grew 8.4% from a year ago, slowing from 11.5% growth in the second quarter. By our math, net account balances grew by $178.4 million during the third quarter compared to $681.3 million in the year-ago period, reflecting normal seasonal patterns and policy surrenders.
The diluted share count fell 4.4% from 98.6 million a year ago and 0.7% from 95.0 million last quarter. Because CNO kept its quarterly buyback spend steady at $60.0 million while buying shares at a higher average price of $54.52 (vs $46.57 in Q2), it retired 1.1 million shares compared to 1.3 million last quarter.
🔮 Guidance
Raised. CNO lifted the middle of its full-year operating profit per share plan by 9%, putting the new midpoint at $5.12 by our math, or 27% growth for the year. Because the first three quarters already produced $3.73 per share excluding the actuarial review, the new midpoint leaves $1.39 for the fourth quarter—down 5.4% from $1.47 a year ago. Second raise this year after holding in Q1 (+$0.35 in Q2, +$0.42 in Q3).
❓ Key Questions
Did the actuarial review hurt Medicare supplement margins?
Medicare supplement margin dropped from 22% of policy income in Q2 to 2% ($3.2 million) in Q3 as benefits jumped $37.8 million from last quarter. Investors need to know how much of that spike came from annual assumption changes versus higher medical claims.
Why does the raised outlook still imply a Q4 drop?
Raising the full-year operating profit per share midpoint by 9% to about $5.12 leaves $1.39 for Q4 by our math, down 5% from $1.47 in Q4 2025. Management should clarify whether it expects unallocated investment income to fall or overhead costs to jump.
When will the Bermuda unit send cash to the parent?
The U.S. insurance units paid zero dividends to the parent company in Q3, and CNO just closed a third Bermuda reinsurance transfer on October 1. Reaching the $200 million to $250 million full-year cash flow target depends on fourth-quarter regulatory approvals.
What was the exact sales breakdown between divisions in Q3?
The release confirmed a 17th straight quarter of total new annualized premium growth, but page 11 of the supplement was not included in the filing. The division split will show whether Consumer life sales kept shrinking while Worksite carried the total.